novocure(NVCR) - 2024 Q1 - Earnings Call Transcript
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Company Participants Ingrid Goldberg - Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Ashley Cordova - Chief Financial Officer Frank Leonard - Executive VP and President of NovoCure Oncology Nicolas Leupin - Chief Medical Officer Conference Call Participants Jason Bednar - Piper Sandler Jonathan Chang - Leerink Partners Jessica Fye - J.P. Morgan Chase Emily Bodnar - H.C. Wainwri ...